EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Sarcopenia and Cardiovascular Diseases

Abdulla A Damluji iD, Maha Alfaraidhy iD, Noora AlHajri, Namit N Rohant, Manish Kumar, Christina Al Malouf, Samira Bahrainy iD, Min Ji Kwak iD, Wayne B Batchelor iD, Daniel E Forman iD, Michael W Rich, James Kirkpatrick und 6 weitere

Circulation · 16.05.2023 · 147 (20) · 1534-1553

DOI: 10.1161/circulationaha.123.064071 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Circulation, erschienen am 16.05.2023. Verfasst von Abdulla A Damluji und 17 weiteren Autor:innen. Beteiligte Einrichtung: Inova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, VA (A.A.D., W.B.B., C.R.D.). Hauptthemen laut MEDLINE: Sarcopenia, Cardiovascular Diseases. Die Arbeit wurde bisher 660-mal zitiert (Crossref) und nennt 239 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: RRD VA, NIA NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by chronic comorbidities including cardiovascular diseases, chronic kidney disease, and cancer. Sarcopenia is associated with faster progression of cardiovascular diseases and higher risk of mortality, falls, and reduced quality of life, particularly among older adults. Although the pathophysiologic mechanisms are complex, the broad underlying cause of sarcopenia includes an imbalance between anabolic and catabolic muscle homeostasis with or without neuronal degeneration. The intrinsic molecular mechanisms of aging, chronic illness, malnutrition, and immobility are associated with the development of sarcopenia. Screening and testing for sarcopenia may be particularly important among those with chronic disease states. Early recognition of sarcopenia is important because it can provide an opportunity for interventions to reverse or delay the progression of muscle disorder, which may ultimately impact cardiovascular outcomes. Relying on body mass index is not useful for screening because many patients will have sarcopenic obesity, a particularly important phenotype among older cardiac patients. In this review, we aimed to: (1) provide a definition of sarcopenia within the context of muscle wasting disorders; (2) summarize the associations between sarcopenia and different cardiovascular diseases; (3) highlight an approach for a diagnostic evaluation; (4) discuss management strategies for sarcopenia; and (5) outline key gaps in knowledge with implications for the future of the field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaCardiovascular DiseasesHumansQuality of LifeBody CompositionMuscle StrengthMuscle, Skeletal

Stichwörter der Autor:innen

body mass indexcardiovascular diseasesolder adultssarcopenia

Autor:innen und Institutionen

  • Inova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, VA (A.A.D., W.B.B., C.R.D.).
  • Johns Hopkins University School of Medicine, Baltimore, MD (A.A.D., M.A., G.G.).
  • Cleveland Clinic, Abu Dhabi, United Arab Emirates (N.A.).
  • University of Arizona, Tucson (N.N.R., P.G.).
  • University of Connecticut, Hartford (M.K.).
  • Weill Cornell Medicine, New York, NY (C.A.M.).

ORCID-Profile: Abdulla A Damluji, Maha Alfaraidhy, Samira Bahrainy, Min Ji Kwak, Wayne B Batchelor, Daniel E Forman, Karen P Alexander, Gary Gerstenblith, Christopher R deFilippi, Parag Goyal

Förderung

  • RRD VA
  • NIA NIH HHS
  • NCI NIH HHS
  • NHLBI NIH HHS

Zitieren

APA

Damluji, A. A., Alfaraidhy, M., AlHajri, N., Rohant, N. N., Kumar, M., Al Malouf, C., Bahrainy, S., Ji Kwak, M., Batchelor, W. B., Forman, D. E., Rich, M. W., Kirkpatrick, J., Krishnaswami, A., Alexander, K. P., Gerstenblith, G., Cawthon, P., deFilippi, C. R., & Goyal, P. (2023). Sarcopenia and Cardiovascular Diseases. Circulation, 147(20), 1534-1553. https://doi.org/10.1161/circulationaha.123.064071

Vancouver

Damluji AA, Alfaraidhy M, AlHajri N, Rohant NN, Kumar M, Al Malouf C, et al. Sarcopenia and Cardiovascular Diseases. Circulation. 2023;147(20):1534-1553. doi:10.1161/circulationaha.123.064071

BibTeX
@article{Damluji2023,
  author = {Damluji, Abdulla A and Alfaraidhy, Maha and AlHajri, Noora and Rohant, Namit N and Kumar, Manish and Al Malouf, Christina and Bahrainy, Samira and Ji Kwak, Min and Batchelor, Wayne B and Forman, Daniel E and Rich, Michael W and Kirkpatrick, James and Krishnaswami, Ashok and Alexander, Karen P and Gerstenblith, Gary and Cawthon, Peggy and deFilippi, Christopher R and Goyal, Parag},
  title = {Sarcopenia and Cardiovascular Diseases},
  journal = {Circulation},
  year = {2023},
  volume = {147},
  number = {20},
  pages = {1534--1553},
  doi = {10.1161/circulationaha.123.064071}
}
Kostenlos starten →